Journal of Maharashtra Orthopaedic Association JAN – MARCH 2014

Journal of Maharashtra Orthopaedic Association 

Jan – March 2014 | Year 9 | Issue 1

ISSN 2278 – 6651

Table of Contents

Editorial

Dr. Avinash Pulate

Download fulltext PDF

Original Articles

2. Less acceptable subjective outcome to patient, despite what may appear satisfactory to Orthopaedic Surgeon about objective results in Colles fractures

Dr. R S Kulkarni

Download Full Text PDF

 

3. Prospective Study of Unstable Intertrochanteric Fractures Treated with Proximal Femoral Nail

Dr.Sandeep Pangavane, Dr. Nitin Wagh, Dr. Chaitanya Karande Patil, Dr. Akshay Gadiya

Download Full Text PDF

 

4. Damage control orthopaedics….The Act of Balancing

Dr. Avinash Pulate, Dr. Nitin Wagh, Dr. Shreyas Vaghasia, Dr. Sagar Kakatkar

Download Full Text PDF

 

Case Reports

5. Aneurysmal bone cyst of the calcaneum in a 6 years old child – treated with curettage and use of allograft: A case report

Dr. Sampat Dumbre Patil, Dr. Wavre Shankar Dnyanoba,  Dr. Keswani Harish, Dr. Vaishali Sampat DumbrePatil, Dr. Harshe Amol

Download Full Text PDF

 

6.Titanium Elastic nailing system for Unicameral bone cyst in pathological neck femur fracture in 6 year old child

 Dr.Anil P.Jadhav, Dr. Avinash M.Pulate, Dr. Satyen P. Joshi, Dr. Riteshkumar S.Jarande

Download Full Text PDF

 

7. Chronic iatrogenic radial nerve palsy with complete recovery after external neurolysis- a case report.

Dr. Hemant Prakash Parekh, Dr. Pramod Lokhande, Dr. Naveen Shejale,  Dr. Samir Chandrakant Dwidmuthe

Download Full Text PDF

 

8. Idiopathic Massive Tarsal Coalition of Bilateral Feet – A Case Report and Review of Literature

Dr. Nakul Shah, Dr. Nilesh Darawade, Dr. Ashish Ranade, Dr. Madhav Khadilkar

Download Full Text PDF

 

9. Book Review : Clinical Examination in Orthopaedics by Dr Mohan K Iyer

 Dr. Ashok Shyam

Download Full Text PDF

 

10. Letter to Editor

Dr. Sachin Jain 

Download Full Text PDF

1 Comment

  1. cidofovir, brand name vistide, is an injectable antiviral medication primarily used as a treatment for cytomegalovirus (cmv) retinitis (an infection of the retina of the eye) in people with aids.

    cidofovir was approved for medical use in 1996.

    medical use
    dna virus
    its only indication that has received regulatory approval worldwide is cytomegalovirus retinitis. cidofovir has also shown efficacy in the treatment of aciclovir-resistant hsv infections. cidofovir has also been investigated as a treatment for progressive multifocal leukoencephalopathy with successful case reports of its use. despite this, the drug failed to demonstrate any efficacy in controlled studies. cidofovir might have anti-smallpox efficacy and might be used on a limited basis in the event of a bioterror incident involving smallpox cases. brincidofovir, a cidofovir derivative with much higher activity against smallpox that can be taken orally has been developed. it has inhibitory effects on varicella-zoster virus replication in vitro although no clinical trials have been done to date, likely due to the abundance of safer alternatives such as aciclovir. cidofovir shows anti-bk virus activity in a subgroup of transplant recipients. cidofovir is being investigated as a complementary intralesional therapy against papillomatosis caused by hpv.

    it first received fda approval on 26 june 1996, tga approval on 30 april 1998 and ema approval on 23 april 1997.

    it has been used topically to treat warts.

Leave a Reply

Your email address will not be published.